Purple Biotech annual net debt
2019
2020
2021
2022
2023
2024
2025
Purple Biotech Net Debt Growth & History (PPBT)
Purple Biotech's net debt was −$8.5M for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$8.5M | −$1.3M | — |
| 2024 | 2024-12-31 | −$7.2M | $6.9M | — |
| 2023 | 2023-12-31 | −$14.1M | $325,000 | — |
| 2022 | 2022-12-31 | −$14.4M | −$4.4M | — |
| 2021 | 2021-12-31 | −$10.0M | $184,000 | — |
| 2020 | 2020-12-31 | −$10.2M | −$6.0M | — |
| 2019 | 2019-12-31 | −$4.2M | — | — |
Purple Biotech quarterly net debt
Q2.19
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$5.1M | −$469,000 | — |
| Q1 2026 | 2026-03-31 | −$5.4M | — | — |
| Q4 2025 | 2025-12-31 | −$8.5M | −$1.3M | — |
| Q3 2025 | 2025-09-30 | −$9.3M | — | — |
| Q2 2025 | 2025-06-30 | −$4.6M | — | — |
| Q4 2024 | 2024-12-31 | −$7.2M | $6.9M | — |
| Q4 2023 | 2023-12-31 | −$14.1M | $325,000 | — |
| Q4 2022 | 2022-12-31 | −$14.4M | −$4.4M | — |
| Q4 2021 | 2021-12-31 | −$10.0M | $184,000 | — |
| Q4 2020 | 2020-12-31 | −$10.2M | −$6.0M | — |
| Q4 2019 | 2019-12-31 | −$4.2M | — | — |
| Q2 2019 | 2019-06-30 | −$2.4M | — | — |
Purple Biotech net debt trends
Over the last five fiscal years, Purple Biotech's net debt increased from −$10.2M to −$8.5M, a change of $1.7M. The latest reported quarter, Q2 2026, shows −$5.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗